Drug Trial Radar · NCT05308264
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
Last checked: Nov 20, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
86
Planned (sponsor's estimate)
Start
Sep 12, 2022
Primary completion
Dec 2027
Study completion Dec 2028
Sponsor
- Lead sponsor
- Rigel PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Apr 4, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase 1b Study of R289 in Patients with Lower-risk Myelodysplastic Syndromes (LR MDS)
Conditions
- Low Risk Myelodysplastic Syndromes
Interventions
R906289 Monosodium (R289 Na)Drug
Drug: R906289 Monosodium (R289 Na) R906289 Monosodium (250mg PO qd, 250mg PO bid, 500 mg PO qd, 500 mg PO bid, 750 mg PO qd, split dose - 500 mg PO AM/250 mg PO PM)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and TolerabilityTime frame: 2 Year
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
University of California, Los Angeles
Los Angeles, California · Recruiting
University of California, Irvine
Orange, California · Recruiting
Stanford Cancer Institute
Palo Alto, California · Recruiting
University of Miami
Miami, Florida · Recruiting
WashU Medicine
St Louis, Missouri · Recruiting
Oncology Clinical Research Referral Office
Hackensack, New Jersey · Recruiting
Ichan School of Medicine at Mount Sinai
New York, New York · Recruiting
Duke Cancer Institute
Durham, North Carolina · Recruiting
Cleveland Clinic
Cleveland, Ohio · Recruiting
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio · Recruiting
University of Texas, Southwestern
Dallas, Texas · Recruiting
MD Anderson Cancer Center
Houston, Texas · Recruiting
Intermountain Healthcare
Salt Lake City, Utah · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.